A detailed history of Menard Financial Group LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Menard Financial Group LLC holds 6,268 shares of ABBV stock, worth $1.04 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares
6,268
Previous 6,454 2.88%
Holding current value
$1.04 Million
Previous $1.11 Million 11.84%
% of portfolio
0.85%
Previous 0.82%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $30,474 - $37,075
-186 Reduced 2.88%
6,268 $1.24 Million
Q2 2024

Aug 09, 2024

BUY
$154.79 - $180.76 $266,857 - $311,630
1,724 Added 36.45%
6,454 $1.11 Million
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $482,976 - $550,306
3,022 Added 176.93%
4,730 $861,000
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $40,344 - $46,704
-302 Reduced 15.02%
1,708 $254,000
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $51,546 - $64,146
389 Added 24.0%
2,010 $270,000
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $6,039 - $6,926
-45 Reduced 2.7%
1,621 $218,000
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $90,141 - $114,598
-655 Reduced 28.22%
1,666 $255,000
Q1 2022

Apr 25, 2022

SELL
$131.98 - $163.75 $3,035 - $3,766
-23 Reduced 0.98%
2,321 $376,000
Q4 2021

Feb 14, 2022

SELL
$107.43 - $135.93 $29,435 - $37,244
-274 Reduced 10.47%
2,344 $317,000
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $1,489 - $1,690
-14 Reduced 0.53%
2,618 $282,000
Q2 2021

Aug 11, 2021

BUY
$105.21 - $117.21 $10,100 - $11,252
96 Added 3.79%
2,632 $296,000
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $4,808 - $5,293
47 Added 1.89%
2,536 $274,000
Q4 2020

Feb 09, 2021

BUY
$80.49 - $108.67 $200,339 - $270,479
2,489 New
2,489 $267,000
Q3 2020

Nov 12, 2020

SELL
$85.91 - $100.83 $200,256 - $235,034
-2,331 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $171,025 - $228,857
2,331 New
2,331 $229,000
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $242,713 - $367,983
-3,763 Closed
0 $0
Q4 2019

Feb 13, 2020

BUY
$72.13 - $90.25 $271,425 - $339,610
3,763 New
3,763 $333,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $294B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Menard Financial Group LLC Portfolio

Follow Menard Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Menard Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Menard Financial Group LLC with notifications on news.